Advertisement
Advertisement

CAMP

CAMP logo

CAMP4 Therapeutics Corporation Common Stock

4.20
USD
Sponsored
+0.28
+7.14%
Jun 26, 16:00 UTC -4
Closed
exchange

After-Market

4.05

-0.15
-3.55%

CAMP4 Therapeutics Corporation Common Stock Profile

About

CAMP4 Therapeutics Corporation is a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases. CAMP4 Therapeutics Corporation is based in CAMBRIDGE, Mass.

Info & Links

CEO

Josh Mandel-Brehm

Headquarters

ONE KENDALL SQUARE, BUILDING 1400 WEST, 3RD FLOOR
CAMBRIDGE, MA 02139, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.camp4tx.com

Auditor

Ernst & Young LLP

Share holders

42

Employees

48

CAMP4 Therapeutics Corporation Common Stock Statistics

Valuation Measures

Market Capitalization2

210.35M

Enterprise Value

110.41M

Enterprise Value/EBITDA(ttm)

-2.17

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

66.64

Price to Book(mrq)

4.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-2298.54%

Profit Margin(ttm)

-3941.25%

Return on Equity(ttm)

-162.49%

Return on Invested Capital(ttm)

-165.67%

Return on Assets(ttm)

-101.06%

Income Statement

Revenue(ttm)

3.93M

Revenue Per Share(ttm)

0.08

Gross Profit(ttm)

3.93M

EBITDA(ttm)3

-50.79M

Net Income Available to Common(ttm)

-86.30M

Diluted EPS(ttm)

-2.66

Share Statistics

Beta (5Y Monthly)

0.41

52-Week Change

169.23%

S&P 500 52-Week Change

18.52%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

51.93M

Dividend Yield

0.00%

Float4

34.47M

% Held by Insiders

33.60%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

99.94M

Total Cash Per Share(mrq)

1.92

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.06%

Current Ratio(mrq)

7.35%

Quick Ratio(mrq)

7.35%

Book Value Per Share(mrq)

0.92

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.97

Free Cash Flow(ytd)

-29.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement